ClearPoint Neuro, Inc. SEC filings CLPT
ClearPoint Neuro, Inc. has 1,006 filings in SEC EDGAR's recent list, going back to Jul 2, 2014. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Feb 5, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2026 | — |
| EFFECT | Filing | Jan 22, 2026 | — |
| CORRESP | Letter to the SEC | Jan 20, 2026 | — |
| EFFECT | Filing | Nov 20, 2023 | — |
| CORRESP | Letter to the SEC | Nov 17, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| CT ORDER | Filing | Dec 15, 2021 | — |
| EFFECT | Filing | Jan 29, 2021 | — |
| CORRESP | Letter to the SEC | Jan 27, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2021 | — |
| CERT | Filing | Dec 6, 2019 | — |
| 25 | Filing | Dec 6, 2019 | — |
| 8-A12B | Filing | Dec 6, 2019 | — |
| CERT | Nyse american certification | Jul 2, 2019 | — |
| 8-A12B | 8-a12b filing | Jul 1, 2019 | — |
| D | Filing | May 29, 2019 | — |
| CT ORDER | Filing | Nov 27, 2018 | — |
| EFFECT | Filing | Jun 6, 2018 | — |
| EFFECT | Filing | Sep 19, 2017 | — |
| EFFECT | Filing | Jul 19, 2017 | — |
| EFFECT | Filing | Jul 7, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2017 | — |
| CORRESP | Letter to the SEC | Jul 5, 2017 | — |
| D | Filing | Jun 6, 2017 | — |
| CT ORDER | Filing | May 16, 2017 | — |
| EFFECT | Filing | Apr 24, 2017 | — |
| EFFECT | Filing | Jan 30, 2017 | — |
| EFFECT | Filing | Oct 11, 2016 | — |
| CORRESP | Letter to the SEC | Oct 6, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 6, 2016 | — |
| CORRESP | Letter to the SEC | Oct 6, 2016 | — |
| D | Filing | Sep 13, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 24, 2016 | — |
| RW | Rw filing | Aug 19, 2016 | — |
| CORRESP | Letter to the SEC | Aug 19, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2016 | — |
| EFFECT | Filing | Aug 8, 2016 | — |
| CORRESP | Letter to the SEC | Aug 5, 2016 | — |
| CORRESP | Letter to the SEC | Aug 5, 2016 | — |
| CERTNAS | Auto-generated paper document | Aug 2, 2016 | — |
| CORRESP | Letter to the SEC | Aug 1, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2016 | — |
| 8-A12B | 8-a12b filing | Jul 6, 2016 | — |
| EFFECT | Filing | Jun 20, 2016 | — |
| CORRESP | Letter to the SEC | Jun 16, 2016 | — |
| EFFECT | Filing | Feb 1, 2016 | — |
| EFFECT | Filing | Jan 29, 2016 | — |
| CORRESP | Letter to the SEC | Jan 27, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2016 | — |
| D | Filing | Dec 21, 2015 | — |
| EFFECT | Filing | Aug 26, 2015 | — |
| CORRESP | Letter to the SEC | Aug 24, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 21, 2015 | — |
| EFFECT | Filing | Jan 26, 2015 | — |
| D | Filing | Dec 23, 2014 | — |
| CT ORDER | Filing | Sep 3, 2014 | — |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- CLPT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Solana Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1285550
- Former names
- MRI INTERVENTIONS, INC. (until Feb 11, 2020); SURGIVISION INC (until Oct 22, 2010); SURGI VISION INC (until May 2, 2007)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.